What's on Practical Law?
China: SAMR conditionally clears Simcere Pharmaceutical/Tobishi Pharmaceutical transaction
Practical Law UK Legal Update w-040-8494 (Approx. 3 pages)
China: SAMR conditionally clears Simcere Pharmaceutical/Tobishi Pharmaceutical transaction
by Freshfields Bruckhaus Deringer LLP, China
Freshfields Bruckhaus Deringer LLP, China
On 22 September 2023, the State Administration for Market Regulation (SAMR) announced that it had conditionally approved Simcere Pharmaceutical (Simcere Pharma)’s proposed acquisition of Beijing Tobishi Pharmaceutical (Tobishi).
Get full access to this document with a free trial
Try free and see for yourself how Practical Law resources can improve productivity, efficiency and response times.
About Practical Law
This document is from Thomson Reuters Practical Law, the legal know-how that goes beyond primary law and traditional legal research to give lawyers a better starting point. We provide standard documents, checklists, legal updates, how-to guides, and more.
Learn more- Expert Guidance
650+ full-time experienced lawyer editors globally create and maintain timely, reliable and accurate resources across all major practice areas.
- Trust
83% of customers are highly satisfied with Practical Law and would recommend to a colleague.
- Improve Response Time
81% of customers agree that Practical Law saves them time.
End of Document
Also Found In
Resource ID w-040-8494© 2024 Thomson Reuters. All rights reserved.